drugset

drugset / Trial / NCT01721460

Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus

NCT01721460 ↗

Phase 4 Completed 6 enrolled University of Wisconsin, Madison

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to find out whether dexmedetomidine changes brain cell activity in the subthalamic nucleus (STN).

Timeline

Start: 2012-11
Primary completion: 2015-06
Completion: 2015-06

Publications

Amlong C, Rusy D, Sanders RD, Lake W, Raz A. Dexmedetomidine depresses neuronal activity in the subthalamic nucleus during deep brain stimulation electrode implantation surgery. BJA Open. 2022 Sep 9;3:100088. doi: 10.1016/j.bjao.2022.100088. eCollection 2022 Sep.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexmedetomidine	Other / unclassified	0.7 ug/kg	—

Indications